ProMIS Neurosciences Ret. on equity
What is the Ret. on equity of ProMIS Neurosciences?
The Ret. on equity of ProMIS Neurosciences, Inc. is -283.78%
What is the definition of Ret. on equity?
Return on equity is a measure of the profitability of a business in relation to the book value of the shareholder equity. It is computed by dividing fiscal year net income by total shareholder equity.
ttm (trailing twelve months)
The return on equity (ROE) ROE is a measure of how well a company uses investments to generate earnings growth. ROE is used for comparing the performance of companies in the same industry. It indicated the management's ability to generate income from the equity available to it. ROEs of 15-20% are generally considered good. ROEs are also a factor in stock valuation, in association with other financial ratios. In general, stock prices are influenced by earnings per share (EPS), so that stock of a company with a 20% ROE will generally cost twice as much as one with a 10% ROE.
Ret. on equity of companies in the Health Care sector on TSX compared to ProMIS Neurosciences
What does ProMIS Neurosciences do?
ProMIS Neurosciences, Inc. discovers and develops precision medicine solutions for the treatment of neurodegenerative diseases, primarily Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA) in Canada. The company's proprietary discovery platform comprises ProMIS and Collective Coordinates algorithms to predict novel targets known as disease specific epitopes on the molecular surface of misfolded proteins. Its lead product candidates include PMN310, a monoclonal antibody (mAb) for toxic oligomers in AD; PMN267, a superoxide dismustase 1 and TAR-DNA binding protein 43 in ALS, as well as alpha synuclein in Parkinson's disease and Lewy body dementia; and PMN442, a mAb targeting toxic a-syn oligomers and seeding fibrils in MSA. The company was formerly known as Amorfix Life Sciences Ltd. and changed its name to ProMIS Neurosciences, Inc. in July 2015. ProMIS Neurosciences, Inc. was incorporated in 2004 and is headquartered in Toronto, Canada.
Companies with ret. on equity similar to ProMIS Neurosciences
- Sprott Resource has Ret. on equity of -284.98%
- Srhi Inc has Ret. on equity of -284.98%
- Medicrea International SA has Ret. on equity of -284.52%
- Medicrea International SA has Ret. on equity of -284.52%
- NewRange Gold has Ret. on equity of -284.37%
- Xantippe Resources has Ret. on equity of -284.37%
- ProMIS Neurosciences has Ret. on equity of -283.78%
- LGL Systems Acquisition Corp has Ret. on equity of -282.99%
- Galilee has Ret. on equity of -282.50%
- Future Consumer has Ret. on equity of -281.63%
- Titanium has Ret. on equity of -281.55%
- Itaconix plc has Ret. on equity of -281.45%
- Emu NL has Ret. on equity of -281.40%